HomeJapan

Japan

Parex Network Advances Ecosystem Accessibility Through Verification and Integration

Tokyo, Japan, 11th December 2024, Chainwire

Mawari Announces Node Sale to Bring Immersive Content to the World

Tokyo, Japan, 31st October 2024, Chainwire

Reflexivity Raises $30M in Series B Funding

Reflexivity (formerly Toggle AI), a London, UK- NYC, Tokyo, Japan-based provider of innovative artificial intelligence solutions for the investment industry, raised $30M in Series B...

Alpha Fusion Raises Series B Funding

Alpha Fusion, an Osaka, Japan-based company bringing bringing "Targeted Alpha Therapy (TAT) using Astatine (At-211)" to cancer patients worldwide, raised ¥1.02 Billion in Series...

Rege Nephro Co. Closes Series B Funding

Rege Nephro Co., Ltd., a Kyoto, Japan-based clinical-stage biotech company, developed a funding plan of total 25 billion yen in new Series B funding and raised 22.5...

Toyoda Gosei Invests in TriOrb

TriOrb Inc., a Fukuoka, Japan-based robotics startup, received an investment from Toyoda Gosei Co., Ltd. (TOKYO:7282). The investment was made in September 2024, through Toyoda Gosei’s...

double jump.tokyo Raises $10M in Funding

double jump.tokyo, a Tokyo, Japan-based startup that specializes in Web3 solutions and developing blockchain games, raised $10M in funding. The round, which marked the first...

ThinkCyte Raises $15M; Closes $32M Series C

ThinkCyte, a Tokyo, Japan- and Redwood City, CA-based biotechnology company developing scientific instruments, raised raised an additional $15M in the extension round, bringing the total Series...

RevolKa Closes US$1.7M Series A Extension Funding

RevolKa, a Tokyo, Japan-based biotech company advancing an AI-driven protein engineering technology platform, raised US$0.7M and completed a US$1.7M in Series A funding. D3...

Renalys Pharma Closes ¥6.0Bn Series A Financing

Renalys Pharma, a Tokyo, Japan-based late-stage clinical biopharmaceutical company, raised a ¥6.0Bn in Series A funding. The round was led by Catalys Pacific and SR...

Dioseve Completes USD7M Funding

Dioseve Inc., a Tokyo, Japan-based developer of assisted reproductive technology using oocytes derived from iPS cells, raised USD7m in funding. Backers included Spiral Capital, Archetype...

THE DAILY NEWSLETTER - SIGNUP